← All trials
NCT05194007
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 19, 2022
- Primary completion
- Jan 31, 2024
- Completion date
- Jan 31, 2025
- First posted
- Jan 18, 2022
- Last posted
- Apr 6, 2022
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Mohammed Bin Rashid University of Medicine and Health SciencesLead sponsor
- Government of DubaiCollaborator
- Mediclinic Middle EastCollaborator
- Mohammed Bin Rashid University of Medicine and Health SciencesReponsible party - principal investigator
- Mohammed Bin Rashid University of Medicine and Health SciencesSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.